Concepts (53)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunotherapy | 6 | 2025 | 160 | 2.260 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2025 | 14 | 1.830 |
Why?
|
| Acetylglucosamine | 2 | 2023 | 17 | 1.040 |
Why?
|
| Killer Cells, Natural | 1 | 2025 | 63 | 0.910 |
Why?
|
| Adjuvants, Immunologic | 2 | 2023 | 68 | 0.870 |
Why?
|
| gamma-Globulins | 1 | 2023 | 3 | 0.860 |
Why?
|
| Squalene | 1 | 2023 | 3 | 0.860 |
Why?
|
| Melphalan | 1 | 2023 | 7 | 0.850 |
Why?
|
| Polysorbates | 1 | 2023 | 6 | 0.850 |
Why?
|
| Respiratory Tract Infections | 1 | 2023 | 37 | 0.830 |
Why?
|
| Melanoma, Experimental | 2 | 2024 | 31 | 0.820 |
Why?
|
| Influenza Vaccines | 1 | 2023 | 51 | 0.820 |
Why?
|
| Transcriptome | 1 | 2024 | 213 | 0.800 |
Why?
|
| Breast Neoplasms | 2 | 2025 | 459 | 0.790 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 97 | 0.740 |
Why?
|
| Neoplasms | 2 | 2020 | 808 | 0.730 |
Why?
|
| Calcium Carbonate | 1 | 2020 | 6 | 0.680 |
Why?
|
| Graphite | 1 | 2020 | 12 | 0.670 |
Why?
|
| Mice | 6 | 2025 | 4659 | 0.560 |
Why?
|
| Nanoparticles | 1 | 2020 | 287 | 0.510 |
Why?
|
| Animals | 7 | 2025 | 10441 | 0.470 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 678 | 0.450 |
Why?
|
| Cell Line, Tumor | 3 | 2024 | 1319 | 0.420 |
Why?
|
| Mice, Inbred BALB C | 2 | 2020 | 276 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 1578 | 0.290 |
Why?
|
| Neoplasm Transplantation | 1 | 2025 | 90 | 0.230 |
Why?
|
| Intraepithelial Lymphocytes | 1 | 2024 | 3 | 0.230 |
Why?
|
| Chitosan | 1 | 2024 | 34 | 0.220 |
Why?
|
| Female | 4 | 2025 | 15157 | 0.210 |
Why?
|
| Biopolymers | 1 | 2023 | 15 | 0.210 |
Why?
|
| Mucous Membrane | 1 | 2023 | 28 | 0.210 |
Why?
|
| Viral Proteins | 1 | 2023 | 63 | 0.210 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 79 | 0.200 |
Why?
|
| Weight Loss | 1 | 2023 | 81 | 0.200 |
Why?
|
| Tumor Microenvironment | 2 | 2024 | 178 | 0.200 |
Why?
|
| Gene Expression Profiling | 1 | 2025 | 451 | 0.200 |
Why?
|
| Risk Assessment | 1 | 2025 | 612 | 0.200 |
Why?
|
| Recombinant Proteins | 1 | 2023 | 413 | 0.190 |
Why?
|
| Mice, Transgenic | 1 | 2023 | 506 | 0.190 |
Why?
|
| Antigens, Neoplasm | 1 | 2022 | 56 | 0.190 |
Why?
|
| Indocyanine Green | 1 | 2020 | 16 | 0.170 |
Why?
|
| Manganese | 1 | 2020 | 24 | 0.170 |
Why?
|
| Infrared Rays | 1 | 2020 | 24 | 0.170 |
Why?
|
| Phototherapy | 1 | 2020 | 28 | 0.170 |
Why?
|
| Theranostic Nanomedicine | 1 | 2020 | 25 | 0.170 |
Why?
|
| Photosensitizing Agents | 1 | 2020 | 35 | 0.170 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2020 | 267 | 0.160 |
Why?
|
| Contrast Media | 1 | 2020 | 96 | 0.160 |
Why?
|
| Humans | 2 | 2025 | 28101 | 0.100 |
Why?
|
| Administration, Topical | 1 | 2024 | 30 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2024 | 300 | 0.050 |
Why?
|
| Melanoma | 1 | 2024 | 140 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2024 | 143 | 0.050 |
Why?
|